Jake’s mother suffered from a haematological disease called Primary Anti-Phospholipid Syndrome (PAPS). The syndrome is associated with obstetric complications such as miscarriage, fetal death, clot formation in the placenta resulting in placental failure, pre-eclampsia and Intra-Uterine Growth Restriction (IUGR).
The central allegations against the Trust were the failures to treat her pregnancy as a “high risk” pregnancy and to advise, establish and enforce a suitable management plan for the pregnancy including ultrasounds and close obstetric surveillance.
Jake was born on 14 August 1996 at 34 weeks gestation by emergency Caesarean section because of fetal distress.
If the obstetricians had followed the management plan for a high risk pregnancy, IUGR would have been diagnosed before 30 weeks gestation. Close surveillance of the pregnancy would have found an abnormal Doppler study and would have resulted in delivery to Jake before he suffered any damage to his brain.
Paul McNeil was instructed to bring a claim against Luton & Dunstable Hospital.
Shortly before the trial which was fixed for the 24 November 2008, the Defendant made a substantial offer to settle the case on a lump sum and annual payments basis. The lump sum will cover the cost of an adapted house and all the aids and appliances Jake requires. The yearly payments, which are updated for inflation, are sufficient to cover the cost of his ongoing care.
At the end of the case, Jake’s mother said:
"Just to say how much we appreciate all your hard work that led to the compensation settlement that will make such a difference to Jake’s life.
"Your attention to detail and great knowledge and skill in this particular type of case reassured us that the outcome would go our way."
You can discuss your obstetric negligence claim with our clinical negligence solicitors on:
Contact us on freephone 0800 358 3848
Or start your claim online.
"The group is praised for its commitment to 'demystifying the legal process' while this is a firm for which the client has always been a priority"
Fieldfisher has successfully been recognised as an "Occupation and Asbestos Disease Specialists" Fieldfisher are now recognised as assessors
Charities we support
Sarah Wolf comments on worrying reports regarding asbestos use in the USA
The Fieldfisher mesothelioma team is closely monitoring the furore that has broken out in the US following reports that the US Environmental Protection Agency (EPA) has paved the way for the use of new products containing asbestos.
The legacy of asbestos
Asbestos mining and manufacturing companies in Wittenoom, Western Australia have left a lasting legacy of the dangers of asbestos.
Peter Williams reacts to multi-billion dollar judgement against Johnson & Johnson in talc claims
American pharmaceutical giant Johnson & Johnson was last week ordered to pay $4.69 billion to 22 women who have suffered ovarian cancer allegedly as a result of using talcum powder contaminated with asbestos.
Fieldfisher out in support of Action Mesothelioma Day 2018
On Friday 6 July 2018, Fieldfisher's Asbestos Team was out in support of Action Mesothelioma Day.